FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Workshop on Generic Drug Perceptions and Reality

[ Price : $8.95]

Federal Register Notice: FDA and Johns Hopkins University Center of Excellence in Regulatory Science and Innovation announce a 11/...

Sarepta Duchenne Drug Approval Gains Voucher

[ Price : $8.95]

Federal Register Notice: FDA issues a priority review voucher to Sarepta Therapeutics after determining its NDA for Duchenne muscu...

Virtus Pharma Sues FDA Over Unapproved Drugs Guidance

[ Price : $8.95]

Virtus Pharmaceuticals files suit against FDA in middle Florida federal court seeking an order barring enforcement action against ...

Leonhard Lang Class 1 Recall of Defibrillator Electrodes

[ Price : $8.95]

Leonhard Lang begins a Class 1 recall of its multi-function defibrillation electrodes DF29N because they will not work with Welch ...

FDA Misses User Fee Date on Pain Drug

[ Price : $8.95]

FDA tells Egalet Corp. that it will not meet a previously announced 10/14 user fee review target date for the pain drug Arymo ER (...

Public Meeting on Generic Drug User Fee Reauthorization

[ Price : $8.95]

FDA announces a 10/21 public meeting to hear public comments on the recent proposed agreement to reauthorize the generic drug user...

Royal Philips Cardia Transducer for Lumify Cleared

[ Price : $8.95]

FDA clears a Royal Philips 510(k) for the S4-1 cardiac transducer for Lumify, asmart-device diagnostic ultrasound solution.

FDA Guide on ANDA Prior Approval Supplements

[ Price : $8.95]

FDA releases a guidance on ANDA Submissions Prior Approval Supplements Under GDUFA that is intended to assist applicants preparin...

FDA Renews Dermatologic/Opthalmic Drugs Panel

[ Price : $8.95]

Federal Register Notice: FDA announces the renewal of the Dermatologic and Ophthalmic Drugs Advisory Committee for an additional t...

FDA Renews Antimicrobial Drugs Panel

[ Price : $8.95]

Federal Register Notice: FDA renews the Antimicrobial Drugs Advisory Committee for an additional two years beyond the charter expi...